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OX40 Promotes Bcl-xL and Bcl-2 Expression
and Is Essential
for Long-Term Survival of CD4 T Cells
(Al-Shamkhani et al., 1996; Calderhead et al., 1993;
Gramaglia et al., 1998; Paterson et al., 1987). OX40L is
also not expressed on resting APC but is induced several
days after activation, by CD40L-CD40 interactions or
nonspecific inflammatory stimuli (Godfrey et al., 1994;
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2Department of Microbiology and Immunology Ohshima et al., 1997; Stuber et al., 1995). OX40 cells are
found in the T cell zones of lymphoid organs followingUniversity of California, San Francisco
San Francisco, California 94143 priming with antigen (Stuber and Strober, 1996), and at
peripheral inflammatory sites (Weinberg et al., 1994, 2000).
Ligation of OX40 on CD4 T cells by agonist reagents
can increase clonal expansion and cytokine productionSummary
(Flynn et al., 1998; Gramaglia et al., 1998, 2000; Maxwell
et al., 2000), enhance memory T cell developmentIt is important to understand which molecules are es-
sential for long-lived immunity. We show that OX40 (Gramaglia et al., 2000; Maxwell et al., 2000) and antitu-
mor immunity (Weinberg et al., 2000), and prevent and(CD134) is required with CD28 for the survival of CD4
T cells following antigen-driven expansion. In contrast reverse the tolerance process (Bansal-Pakala et al.,
2001). There is now a body of evidence which demon-to CD28/ T cells, which show defects early, OX40/
T cells are relatively unimpaired in IL-2 production, strates the natural use of OX40 in several types of T cell
response, with recent data from knockout mice showingcell division, and expansion. However, OX40/ T cells
fail to maintain high levels of Bcl-xL and Bcl-2 4–8 days decreased CD4 response to nominal antigen and in vari-
ous models of disease, all scenarios where CD28 hasafter activation, and undergo apoptosis. Conversely,
OX40 stimulation promotes Bcl-xL and Bcl-2 and sup- been shown to play a role (Chen et al., 1999; Gramaglia
et al., 2000; Jember et al., 2001; Kopf et al., 1999; Muratapresses apoptosis. Moreover, retroviral transduction
of OX40/ T cells with Bcl-xL or Bcl-2 reverses their et al., 2000).
Thus, OX40 is equally as important to a T cell responsesurvival defect. Thus, a temporal relationship exists
between CD28 and OX40, with OX40 being a critical as CD28. However, there has been little direct data to
indicate the mode of action of OX40. We recentlyregulator of antigen-driven T cell survival.
showed that the frequency of antigen-specific memory
T cells was dramatically reduced in OX40-deficient miceIntroduction
after priming (Gramaglia et al., 2000), suggesting that
OX40 may function to regulate T cell survival. In thisAt least two signals are needed for optimal activation
of T cells (Lafferty and Woolnough, 1977). The first is study, we now present direct evidence for this. We dem-
onstrate that OX40 is integral to a response initiated bydelivered by TCR interaction with MHC and peptide, and
the second involves ligation of costimulatory receptors CD28, and that it acts sequentially in a late capacity to
suppress apoptosis of primary CD4 T cells. Moreover, wethat are needed for enhancing cytokine production, aug-
menting cell proliferation, and promoting cell survival. show that the antiapoptotic proteins Bcl-xL and Bcl-2
which are initially regulated by CD28, are also targetsWithout second signals, T cells can become anergic
or undergo apoptosis. The best characterized second of OX40 action. Thus, CD28 and OX40 contribute syner-
gistic signals provided in a temporal fashion, with OX40signal is the interaction of CD28 with CD80 and CD86
(Linsley and Ledbetter, 1993). CD28 can enhance T cell representing an essential late signal that is required to
promote long-term CD4 T cell survival.proliferation (June et al., 1987), cytokine secretion (Jen-
kins et al., 1991), and expression of antiapoptotic pro-
teins such as Bcl-xL (Boise et al., 1995). In vivo studies Results
have supported a dominant role for CD28 in many re-
sponses including contact hypersensitivity, asthma, co- Maximal Expression of OX40 and OX40L Are
litis, EAE, and some viral and certain parasitic infections. Dependent on CD28 Signals
Although CD28 provides a critical signal for naı¨ve T cell In order to characterize the role of OX40 in relation to
activation, additional costimulatory interactions have CD28, we bred OX40/ and CD28/ mice onto the AND
been described which may represent essential compo- (V3/V11) TCR transgenic background. Resting wild-
nents of a long-lived T cell response (Croft and Dubey, type (wt) T cells expressed CD28 but not OX40 (Figure
1997; Watts and DeBenedette, 1999). In particular, re- 1A). OX40 was expressed 1 day after activation with
cent data on OX40 (CD134) and its ligand (CD134L), moth cytochrome c (MCC), and peaked after 3 days
members of the TNFR/TNF superfamily, suggest that (Figure 1B). CD28/ T cells expressed OX40 after activa-
they play a complementary role to CD28. Unlike CD28, tion but expression was delayed, and absolute levels
which is constitutively expressed on resting T cells, were 4-fold lower than on wt T cells. OX40L was ex-
OX40 is only expressed 1 to 2 days after activation pressed on APC between 2 and 4 days with wt T cells
(Figure 1C), with most dendritic cells and 50% B cells
being positive (data not shown). OX40L was minimally3Correspondence: mick_croft@liai.org
4These authors contributed equally to this work. induced in cultures with CD28/ T cells. Therefore,
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Figure 1. CD28 Is Required for Rapid and Maximal Expression of OX40 and OX40L
CD4 T cells from control AND mice (wt), OX40-deficient AND mice (OX40/), and CD28-deficient AND mice (CD28/) were obtained ex vivo
(day 0) or were cultured for varying lengths of time with T-depleted spleen APCs and peptide (1 M).
(A) Expression of CD28 on CD4 cells.
(B) Expression of OX40 on CD4 cells.
(C) Expression of OX40L on non-CD4 cells. OX40L was not found on resting APC. N.d., not done.
CD28 is not required for OX40 expression, but is needed cells generated after priming with KLH was significantly
reduced in OX40/ mice (Gramaglia et al., 2000). Thisto obtain early and maximal expression, and CD28 indi-
suggested that OX40 may control T cell survival, butrectly regulates the induction of OX40L on APC.
did not distinguish between an antiapoptotic effect as
opposed to a decreased ability of T cells to expand inOX40, Unlike CD28, Is Minimally Involved
numbers during the initial phase of the primary re-in the Initial Naı¨ve T Cell Response
sponse. This was determined here by monitoring T cellTo determine whether OX40 functions during the early
survival and death over time (Figure 3). With high-dosenaı¨ve T cell response, OX40/ T cells were stimulated
peptide, part of the long-term viability of wt T cells couldwith peptide presented on splenic APC. Whereas
have been due to continued cell division, as proliferationCD28/ T cells were dramatically impaired in their ability
was still evident at day 5 and day 6 (Figure 2D). Withto produce IL-2 (5% of wt), OX40/ T cells showed only
lower peptide doses, the stability in T cell numbers solelya moderately decreased ability to secrete IL-2 (40%
reflected the capacity to survive, as no proliferation wasof wt; Figure 2A).
seen after 5 days.In contrast to CD28/ T cells, which showed substan-
OX40/ T cells were dramatically impaired in theirtially reduced proliferation at 3 days, OX40/ T cells
ability to survive over time with 60%–80% fewer T cellsproliferated similarly to wt T cells (Figure 2B). By CFSE
being viable 12 days after activation, numbers almostanalysis, after 2 days, there was no difference in the
identical to those in the absence of CD28 (Figures 3Anumber of divided OX40/ cells versus wt cells (Figure
and 3B). Little difference was observed in the number of2C). Again, this was in contrast to CD28/ T cells, which
cells that were initially generated without OX40, whereaslagged behind controls in the number that divided and
there were 50% fewer in the absence of CD28 (Figurethe extent of division. Collectively, this shows that CD28
3B, day 4). The majority of cell death occurred betweencontrols much of the early T cell response with little
day 4 and day 8 in OX40/ T cells (Figure 3C), and thisparticipation of OX40.
was confirmed by demonstrating a markedly greater
number of annexin T cells in OX40/ cultures (Figure
OX40 Controls Late Cell Division and Prolongs 3D, left). The majority of apoptotic OX40/ T cells had
T Cell Turnover undergone four divisions, whereas most apoptotic wt T
The requirement for OX40 for continued T cell expansion cells had undergone five or six divisions (Figure 3D,
was determined. After 5 days, OX40/ T cells had under- middle). This suggests that part of the reduced ability
gone fewer divisions (Figure 2E). Most OX40/ T cells of OX40/ T cells to divide at late times was due to cell
divided, but with a lag in the rate of division. As ex- death. Two main pathways of death were described a
pected, CD28/ T cells were more dramatically im- number of years ago (Strasser et al., 1995), one involving
paired. Proliferation after 5 and 6 days was reduced in signals from TNFR family members possessing death
OX40/ T cells under those antigenic conditions (1 and domains (active cell death) and the second governed
10 M) where proliferation was still evident in control by a number of proteins of the Bcl-2 family (passive
wt populations (Figure 2D). Thus, OX40 prolongs T cell death). Both pathways led to activation of the caspase
division initially induced by CD28. cascade. Demonstrating that defective survival of
OX40/ T cells did involve caspase proteins, the death
OX40 Controls T Cell Survival of OX40/ T cells was efficiently blocked by peptide
by Suppressing Apoptosis inhibitors of several caspases (Figure 3D, right).
Previously, we showed in vivo that the frequency of These results show that a temporal relationship exists,
with CD28 signals acting initially to provide expansionantigen-specific primary effector T cells and memory T
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Figure 2. IL-2 Secretion, Early Proliferation, and Cell Division of OX40-Deficient T Cells Is Only Minimally Impaired Compared to CD28-Deficient
T Cells
Naı¨ve CD4 T cells from wt AND mice (closed circles), OX40-deficient AND mice (open triangles), and CD28-deficient AND mice (open squares)
were stimulated with mitomycin C-treated T-depleted APCs and varying doses of peptide.
(A) IL-2 production at 40 hr. Data are the average and SD from three experiments.
(B) Proliferation at 72 hr. Data are representative of three experiments.
(C) Cell division of CFSE-labeled live CD4 cells 2 days after antigen stimulation. The thick line represents knockout T cells, while the thin line
represents wt T cells. OX40/ and CD28/ data are from different experiments, and are representative of three experiments.
(D) Proliferation after 5 days (left) and 6 days (right). Similar data were seen in three experiments.
(E) Cell division of CFSE-labeled live CD4 cells 5 days after antigen stimulation. OX40/ and CD28/ data are from different experiments,
and are representative of three experiments.
and life signals, followed by OX40 signals which prolong likely reflects the combined lack of both CD28 and OX40
signals due to the lower expression of OX40 on CD28/division at late times and allow survival in the absence
of division by preventing caspase activation. T cells and minimal OX40L on APCs in these cultures
(Figure 1).
After 8 days, the levels of Bcl-xL were significantly
OX40/ T Cells Cannot Maintain High-Level reduced in all populations, with wt as well as OX40/
Expression of the Antiapoptotic Proteins Bcl-xL and CD28/ T cells expressing lesser amounts than at
and Bcl-2 day 4 (Figures 4A–4C). However, Bcl-xL was still lower
Previous studies have suggested that T cell death in the in the absence of OX40 or CD28 signals. Bcl-2 was
late primary response to foreign antigen is brought about maintained at high levels in wt T cells at day 8 but was
by apoptotic mechanisms that do not involve death re- significantly reduced in the absence of OX40 or CD28
ceptors such as Fas (Strasser et al., 1991, 1995; Van (Figures 4A, 4B, and 4D). In contrast, neither CD28 nor
Parijs et al., 1998). Because our system faithfully mimics OX40 affected the levels of the proapoptotic molecule
expansion and contraction of CD4 T cells responding Bax (Figures 4A, 4B, and 4E).
to antigen encountered in an inflammatory environment To investigate whether reduced production of IL-2
in vivo (Gramaglia et al., 2000; Kearney et al., 1994; Van was responsible for the death of OX40/ T cells, cultures
Parijs et al., 1998), it was likely that the death of OX40/ were supplemented with exogenous IL-2 such that lev-
T cells was brought about by passive rather than active els reflected those seen from wt T cells (Figure 4F). A
mechanisms. As previous studies of CD28 showed an positive effect was seen on T cell proliferation after 5 days
action on Bcl-xL and Bcl-2 (Boise et al., 1995; Mueller (Figure 4F, left), but exogenous IL-2 did not rescue sur-
et al., 1996; Sperling et al., 1996), their levels were deter- vival of OX40/ T cells (Figure 4F, middle), nor did it
mined in responding OX40/ T cells (Figure 4). upregulate the levels of Bcl-xL or Bcl-2 (Figure 4F, right).
T cells lacking CD28 or OX40 did not vary appreciably
from wt T cells with respect to Bcl-2 and Bcl-xL early
in response at day 2 (data not shown). However, both Agonist Antibody to OX40 Can Directly Augment
Expression of Bcl-xL and Bcl-2OX40/ and CD28/ T cells exhibited significantly lower
levels of Bcl-xL and Bcl-2 at day 4, a time point that and Suppress Apoptosis
To directly show that OX40 can maintain expression ofprecedes extensive cell death. Levels in CD28/ T cells
were less than in OX40/ T cells (Figures 4A–4D). The Bcl-xL and Bcl-2, and to determine the requirement for
CD28, an agonist antibody to OX40 was used to stimu-more pronounced phenotype of CD28/ T cells most
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Figure 3. Long-Term T Cell Survival Is Severely Reduced in the Absence of OX40
5  105 OX40/ (open triangles), CD28/ (open squares), and wt (closed circles) AND T cells were stimulated with varying doses of peptide
for 4–12 days as in Figure 2. Live CD4 cells were counted by trypan blue exclusion and the percent survival was calculated based on the
input number of cells.
(A) T cell survival on day 12 from three experiments.
(B) A representative experiment out of three, comparing T cell survival on day 4 and day 12 after stimulation with 0.1 M peptide.
(C) A representative experiment out of three, assessing the kinetics of T cell survival after stimulation with 0.1 M peptide.
(D) Left panel shows annexin V staining as a function of cell division with CFSE-labeled T cells. Results show CD4 gated populations at day
6 with 0.1 M peptide. Numbers represent % annexin V T cells and are representative of two experiments. Right panel shows T cell survival
after 8 days in the presence of control peptide or peptide inhibitors of caspase 3, caspase 9, or a global caspase inhibitor given on days 3,
5, and 7. Data are means of responses from all individual inhibitors from two experiments.
late CD28/ T cells (Figure 5A). Anti-OX40 resulted in of which are functional in mouse cells. Death is accom-
panied by the loss of GFP, allowing the survival of trans-elevated Bcl-xL and Bcl-2 levels at late times (2- to 4-fold
above controls). OX40 signals were similar in activity to duced T cells to be followed by flow cytometry. Figure
6 shows a representative experiment comparing theCD28 signals, which also augmented both Bcl-xL and
Bcl-2 in OX40/ T cells. Anti-OX40 only minimally in- transition of T cell populations from day 4 immediately
after transduction and before extensive cell death (Fig-creased IL-2 from naı¨ve T cells (20% with wt or CD28/
cells; Rogers and Croft, 2000 and data not shown), and ure 6A) through to day 12 (Figure 6C). Transduction with
the respective vectors led to high-level expression ofhad no effect on the number of T cells generated over 4
days (Figure 5B). However, anti-OX40 enhanced survival Bcl-xL and Bcl-2 in OX40/ T cells (Figure 6B). After 12
days, only 7% of V3 T cells were alive in MSCV cul-(Figure 5B) and suppressed apoptosis (Figure 5C) at late
times, correlating directly with the positive effects on tures as assessed by F/SSC analysis, versus 54% in
Bcl-xL and Bcl-2 expression. MSCV-Bcl-xL and 25% in MSCV-Bcl-2 cultures (Figure
6C, left). Both Bcl-xL and Bcl-2 suppressed apoptosis
as measured by annexin V staining of V3 T cells (Fig-Retroviral Transduction of Bcl-xL or Bcl-2 Prevents
ure 6C, middle). Moreover, if gene transduction providedDefective Survival of OX40/ T Cells
a survival advantage, it would be expected that the pro-In order to directly demonstrate that defective survival
portion of GFP cells within the live gate would increase.of OX40/ T cells was associated with reduced levels
This was the case with the % GFP remaining constantof the prosurvival members of the Bcl-2 protein family,
with control vector (54% versus 53% on day 4), buta bicistronic retrovirus vector was used to transduce
increasing to 93% and 77% in MSCV-Bcl-xL and MSCV-OX40/ T cells with Bcl-xL or Bcl-2 and green fluores-
Bcl-2 cultures, respectively (Figure 6C, right).cent protein (GFP; Dahl et al., 2000; Ouyang et al., 1998).
Calculation of actual numbers of GFP-expressing TCD4 cells from OX40/ mice were transduced on day
cells directly showed that transduction of Bcl-xL or Bcl-22 and day 3 after activation with vector containing hu-
man Bcl-xL (MSCV-Bcl-xL) or Bcl-2 (MSCV-Bcl-2), both restored the ability of OX40/ T cells to survive over
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Figure 4. Expression of Bcl-xL and Bcl-2 Is Not Maintained over Time in the Absence of OX40
Wt, OX40/, and CD28/ AND T cells were cultured as in Figure 2 with APCs and 1 M peptide for 4 or 8 days. Bcl-xL, Bcl-2, Bax, and actin
levels were measured by Western blotting of equal amounts of protein lysate taken from viable CD4 cells at day 4 (A) or day 8 (B). Graphs
show the relative expression of Bcl-xL (C), Bcl-2 (D), and Bax (E) compared to actin, expressed as a ratio after quantitation by densitometry.
Data shows a representative experiment out of four. Bcl-xL and Bcl-2 levels on day 4 and day 8 ranged from 30%–60% of wt for OX40/
T cells and 15%–40% of wt for CD28/ T cells. T cell proliferation after 5 days (left), T cell survival after 12 days (middle), and Bcl-xL and
Bcl-2 levels after 8 days (right) from cultures of wt or OX40/ T cells stimulated in the presence or absence of exogenous IL-2 (15 ng/ml)
added on day 1 (F). Data are representative of three experiments.
time (Figure 7). Differences were observed between the regulate the subsequent survival of T cells when antigen
becomes limiting. We show that OX40 is required toaction of Bcl-xL and Bcl-2, in that Bcl-xL resulted in
approximately 2-fold expansion in T cell numbers be- maintain high-level expression of the antiapoptotic pro-
teins Bcl-xL and Bcl-2, suggesting that this is a keytween day 4 and day 8, whereas Bcl-2 simply allowed
the T cells to survive without an appreciable change in event which controls the number of memory T cells that
are generated. A temporal sequence can be proposed,number (Figure 7B). This suggests that both Bcl-xL and
Bcl-2 contribute to OX40-induced survival but that there with CD28 providing signal 2 to promote T cell expansion
and survival initiated by antigen and signal 1, and OX40may be differential roles in proliferating versus nonprolif-
erating T cells, with Bcl-xL being more important early in providing an additional late-acting signal which is re-
quired to prolong expansion and further suppress cellresponse, allowing continued expansion of those T cells
still undergoing cell division. death, allowing a proportion of the expanded T cells to
survive. This study suggests an updated view of the two-Collectively, our results provide compelling evidence
that a major target of OX40 is the antiapoptotic proteins signal model of T cell activation to incorporate multiple
sequential signals, and that long-term immunity can onlyof the Bcl-2 family, and that the death of OX40-deficient
T cells is due to an inability to maintain high levels of result when secondary costimulatory signals are pro-
vided several days after the initial activation event.these proteins over time.
Although previous reports of OX40 have highlighted
the importance of this molecule, there has been littleDiscussion
indication of its mode of action and relationship to other
molecules. Our recent study in OX40/ mice showedOX40 has now been shown to play a role in many CD4
that the precursor frequency of effector T cells in theresponses in vivo, including regulating memory T cell
late primary response to KLH was reduced 10- to 40-development. We as well as others have suggested that
fold compared to wt mice, as was the frequency ofa major action of OX40 is to control the overall level of
memory T cells present 5 weeks after priming (Gramagliaclonal expansion in the primary immune response, but
et al., 2000). This also correlated with data which showeddirect data on the mechanism of action of OX40 has
a 4- to 5-fold reduction in the number of IFN--secretingbeen lacking. In this report, we demonstrate that OX40
CD4 cells after LCMV infection of OX40/ mice (Kopfdoes not act in the initial phases of the response, but
et al., 1999). Both reports implied that OX40 signalsthat it acts sequentially after CD28 to regulate late T cell
turnover at the peak of the expansion phase and to regulate the number of antigen-specific T cells that are
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Figure 5. OX40 Ligation Enhances Bcl-xL and Bcl-2 Expression and T Cell Survival, and Suppresses Apoptosis
(A) CD4 T cells from OX40/ and CD28/ AND mice were stimulated with 1 M peptide for 8 days in the presence of control IgG, with agonist
anti-OX40 added on day 0 and day 2 or agonist anti-CD28 added on day 0. Bcl-xL, Bcl-2, Bax, and actin expression were determined by
Western blotting as in Figure 4. Data are representative of three experiments.
(B) Survival (% recovery compared to the input number) of CD4 T cells from wt (circles) and CD28/ (squares) AND mice stimulated with 1
M peptide for 4 and 12 days, in the presence of control IgG (closed symbols) or agonist anti-OX40 (open symbols) added on day 0 and day
2. Data are the average of three separate experiments with standard errors being less than 15% of the means.
(C) Cell death (annexin V staining) of wt T cells labeled with CFSE and stimulated as above for 8 days in the presence of anti-OX40 or control
IgG. Numbers represent the % annexin V T cells. Similar data were seen in one repeat experiment.
generated and/or the number that survive. Other data mediated in part by competitive dimerization between
pairs of molecules (Kroemer, 1997). Thus, the relativedirectly and indirectly supports this. In mice made trans-
genic for OX40L, five times as many CD4 cells were levels of expression of one or more of these molecules
may dramatically affect the propensity of a cell to sur-found in the B cell areas after antigen priming (Brocker
et al., 1999), and in mice receiving a blocking antibody vive. Our data suggest that death in the absence of
OX40 is brought about by passive mechanisms and thatto OX40L, four times fewer T cells were found in the B
cell areas (Walker et al., 1999). In addition, an agonist the antiapoptotic proteins Bcl-xL and Bcl-2 are central
to OX40-mediated survival. In line with this, inhibitoryantibody to OX40, injected in two separate studies into
recipients of adoptively transferred TCR transgenic T reagents of Fas and TNFR (data not shown), as well as
exogenous IL-2, did not prevent the defect in survivalcells primed with either soluble antigen or antigen in
adjuvant, resulted in 4- to 17-fold more cells accumulat- of OX40/ T cells. Bcl-xL is massively induced in naı¨ve
T cells 2 days after activation, peaks at day 4, and subse-ing in the primary response and the development of
4- to 15-fold more memory cells (Gramaglia et al., 2000; quently reverts back to baseline levels as T cells return
to rest. In contrast, Bcl-2 is more moderately elevatedMaxwell et al., 2000). The data presented in this paper
complement these reports, and now conclusively show with slower kinetics and then maintained over time (Fig-
ure 4 and data not shown). Several studies have impliedthat OX40 acts to suppress T cell death, with the effects
being evident at and after the peak of the primary prolif- that Bcl-2 and Bcl-xL are analogous and perform the
same function (Chao et al., 1995; Petschner et al., 1998).erative and expansion phase.
The mechanism of apoptotic death that occurs late As a variation of this idea, it was suggested that Bcl-2
may control the survival of resting T cells, whereas Bcl-in a primary T cell response is controversial. While some
studies support a role for death receptors, others do xL may control the survival of activated effector-type T
cells (Behrens and Mueller, 1997). Thus, maintaining Bcl-not. It is likely that the mechanism may vary, and that
the death of responding T cells in the presence of costi- xL levels might be more important for T cell survival
during the peak of the expansion phase around day 4mulation is fundamentally different from the death of T
cells in the absence of costimulation. Death of T cells to day 6, whereas maintaining Bcl-2 levels might be
more important for the survival of T cells as they revertby neglect (antigen or costimulation) is mediated by
caspases and adaptors that are distinct from those em- back to a more resting state around day 8 and beyond.
The finding that the overall levels of Bcl-2 were higherployed by death receptors (Lenardo et al., 1999; Rath-
mell and Thompson, 1999; Strasser et al., 1995). This than Bcl-xL in wt T cells recovered after 8 days supports
this notion (Figure 4), as does the fact that retroviraltype of death is controlled by the interplay between the
proapoptotic members of the Bcl-2 family such as Bax, transduction of Bcl-xL augmented T cell expansion be-
tween 4 and 8 days, whereas Bcl-2 purely maintainedBad, and Bim and the antiapoptotic members such as
Bcl-xL and Bcl-2. The ratio of antagonists to agonists T cell numbers (Figure 7).
Because the phenotype of CD28/ T cells with re-appears to determine whether apoptosis results, and is
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Figure 6. Retroviral Expression of Bcl-xL and Bcl-2 Suppresses Apoptosis of OX40/ T Cells
CD4 cells from OX40/ AND mice were stimulated with 1 M peptide and APCs. On day 2 and day 3, T cells were transduced with retroviral
vectors expressing GFP alone (MSCV) or GFP with Bcl-2 (MSCV-Bcl-2) or Bcl-xL (MSCV-Bcl-xL). T cells were recultured and analyzed for
survival and death by flow cytometry.
(A) V3/GFP and FSC/SSC profiles of gated V3 T cells in a representative control culture on day 4. Numbers represent % GFP cells and
% V3 cells within the live gate. Similar profiles were seen in Bcl-2- and Bcl-xL-transduced cultures.
(B) Human Bcl-2 (top) and human/mouse Bcl-xL (bottom) expression in live T cells from control and Bcl-2- or Bcl-xL-transduced cultures,
respectively assessed on day 8.
(C) FSC/SSC (left) and annexin V (middle) profiles of gated V3 T cells on day 12 and day 8, respectively. GFP/V3 (right) profiles of cells
within the live F/SSC gate on day 12. Numbers represent % cells in live gate, % annexin cells, and % GFP cells. Data are representative
of two to three separate experiments.
spect to Bcl-xL and Bcl-2 was similar but more dramatic physiological response in only weak provision of OX40
signals. This again highlights the strong cooperationthan that of OX40/ T cells this suggests that CD28/
T cells were in fact behaving as T cells this lacking between these molecules in providing synergistic sig-
nals to suppress death over time. It is clear from theboth CD28 and OX40. OX40 expression was slow and
submaximal in the absence of CD28, and little OX40L data with CD28/ T cells that the expansion phase of
the primary T cell response is largely regulated by CD28,was induced on APCs. The rationale for the latter is
that OX40L expression is regulated by CD40 signals partially through production of IL-2. OX40 may function
to promote continued cell division via increasing the(Ohshima et al., 1997), and only low levels of CD40L are
induced on T cells in the absence of CD28-B7 interac- output of IL-2 and maintaining high levels of Bcl-xL.
OX40 may then provide IL-2-independent survival sig-tions (Jaiswal et al., 1996). Thus, the combined effect
of the absence of CD28 most likely translates during a nals at late times to further suppress cell death that is
Figure 7. Retroviral Expression of Bcl-xL and Bcl-2 Corrects the Defect in Survival of OX40/ T Cells
5  105 CD4 T cells from OX40/ AND mice were stimulated with 1 M peptide and APCs. On day 2 and day 3, T cells were transduced as
in Figure 6 with control retroviral vector (MSCV; closed squares) or vectors expressing Bcl-xL (MSCV-Bcl-xL; open triangles) or Bcl-2
(MSCV-Bcl-2; open circles). T cells were recultured and analyzed on days 4, 8, and 12 for survival by trypan blue exclusion and flow cytometry.
(A) Total numbers of GFP V3 T cells recovered over time from a representative experiment.
(B) GFP V3 T cell recovery normalized to take into account differences in transduction efficiency between cultures. Cell numbers present
on day 4 were assigned a value of 100%. Cell numbers surviving on day 8 and day 12 were used to calculate % recovery relative to day 4.
Data represent mean % change 	 SD from two to three separate experiments.
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initially regulated by CD28, possibly via Bcl-xL, but most sponse, and therefore is critical to the efficient genera-
likely primarily through maintaining Bcl-2 levels. tion of memory. We show that a costimulatory receptor
We can only speculate at the present time how OX40 other than CD28 can regulate antiapoptotic proteins
regulates Bcl-xL and Bcl-2. The one signaling pathway such as Bcl-xL and Bcl-2, and suggest that through this
described for OX40 to date is that involving activation action, OX40 plays a vital role in shaping the overall
of NF-
B (Arch and Thompson, 1998; Kawamata et al., magnitude and longevity of the CD4 response. These
1998). Binding experiments have shown that OX40 sig- data provide a model whereby antigen-specific expan-
nals could be mediated by either TRAF2 or TRAF5 (Arch sion, survival, and differentiation are driven by the con-
and Thompson, 1998; Kawamata et al., 1998), adaptor certed and sequential action of several costimulatory
proteins that are implicated in NF-
B activation by other receptor-ligand pairs of the Ig and TNFR superfamilies.
members of the TNFR family. NF-
B has long been They suggest that a nontolerizing, long-lasting T cell
thought to regulate cell survival (Liu et al., 1996), and response requires multiple interactions to be provided
direct links have now been described between this mole- over a period of many days, most likely brought about
cule and the prosurvival Bcl-2 family proteins (Andjelic during numerous encounters of the T cell with antigen-
et al., 2000; Grumont et al., 1999; Lee et al., 1999). It is presenting cells. It is tempting to speculate that these
therefore likely that NF-
B is the central mediator of the secondary cosignals are principally transmitted by the
effects of OX40 on T cell survival. Interestingly, CD28 TNFR/TNF family of molecules because of their induc-
signaling can also result in NF-
B activation (Harhaj and ible expression on T cells and APC several days after
Sun, 1998; Lin et al., 1999). A common NF-
B pathway initial antigen encounter, and that molecules such as
regulating the antiapoptotic members of the Bcl-2 pro- 4-1BB, CD27, and HVEM will play analogous roles to
tein family provides a rationale for the synergistic tempo- that shown here for OX40.
ral relationship between CD28 and OX40.
Experimental ProceduresCytokine withdrawal has been proposed to be a major
mechanism of passive apoptosis of T cells. However,
Micethe majority of data that relate to this are derived from
AND TCR transgenic mice bearing T cells reactive with peptides ofIL-2-dependent T cell lines (Deng and Podack, 1993;
moth cytochrome c (MCC) and expressing the V3/V11 TCR were
Vasilakos et al., 1995) or non-T cells responding to cyto- bred on a B10.BR background (Croft et al., 1992). CD28-deficient
kines such as IL-3 (del Peso et al., 1997). IL-2 has in mice (CD28/) were obtained from Jackson Laboratories and OX40-
some cases been reported to enhance expression of deficient mice (OX40/) were generated as described (Pippig et al.,
1999). Both strains were backcrossed at least five generations toBcl-2, but IL-2 may also function to promote apoptosis,
AND mice. Thymic selection was normal in the resultant mice, withthrough relieving a block on Fas-mediated death (Refaeli
similar numbers of peripheral CD4 cells in both wt and knockoutet al., 1998). As we saw no effect of exogenous IL-2,
animals. All CD4 cells expressed the transgenic TCR.
our data on OX40, combined with previous data and
that here on CD28, suggest that passive apoptosis may Peptides and Antibodies
be equally governed by a lack of direct costimulatory T102S, a variant superagonist of MCC (amino acids 88–103; ANERA
DLIAYKQASK), was synthesized at LIAI (Rogers and Croft, 2000).signals as by a lack of cytokine receptor signals. Apopto-
Anti-OX40 (OX86) was obtained from the European cell culture col-sis associated with cytokine withdrawal can involve Bad
lection (Wiltshire, UK). Anti-CD28 (37.51) was obtained from Dr. J.P.(del Peso et al., 1997), although recent data suggest
Allison (University of California, Berkeley).that Bim may be the physiological regulator of passive
apoptosis in T cells (Bouillet et al., 1999; Puthalakath et T Cells and APC
al., 1999). Both molecules can competitively dimerize CD4 T cells were purified from spleen and lymph nodes of TCR
with Bcl-xL and Bcl-2 and inhibit their antiapoptotic ac- transgenic mice by nylon wool depletion, followed by Ab and com-
plement treatment as described (Croft et al., 1992). The resultingtion (Puthalakath et al., 1999; Yang et al., 1995). Bad is
cells were 90% CD4, and 95% of these cells expressed theinactivated by PI-3-kinase and Akt (del Peso et al., 1997),
V3/V11 TCR. APC were isolated from spleens of B10.BR mice byand PI-3-kinase has been implicated in downregulating
depleting T cells. APC were treated with mitomycin c (100 g/ml)Bim (Shinjyo et al., 2001). Thus, it is possible that Bim
for 30 min at 37C before use, which results in their death after
or Bad are also direct targets of costimulatory signals. 72–96 hr.
PI-3-kinase and Akt have been associated with CD28
signaling (Parry et al., 1997), and several studies of TNF/ Cell Cultures
Cultures were set up in 48-well plates containing 1 ml of RPMI 1640TNFR family members including TNF, TRANCE, and
(Irvine Scientific) supplemented with 10% fetal calf serum (OmegaCD40 (Andjelic et al., 2000; Ozes et al., 1999; Pastorino
Scientific). Naı¨ve CD4 cells were plated at 5  105/ml with 2  106/et al., 1999; Wong et al., 1999) have also demonstrated
ml APCs and various concentrations of T102S peptide. In somethe use of PI-3-kinase and Akt. It remains to be deter-
experiments, stimulatory antibodies to CD28 (4 g/ml) or OX40 (10
mined whether the antiapoptotic effects of OX40 and
g/ml) were added at 0 hr, and 0 and 48 hr, respectively. Both were
CD28 are simply due to elevating and maintaining the compared to control rat and hamster IgG. A global caspase inhibitor
levels of Bcl-xL and Bcl-2, or whether they also involve (Boc-D(OMe)-FMK; Alexis Corporation), a caspase 3, or a caspase
9 inhibitor (Ac-DEVD-CHO and Z-LE(OMe)HD(OMe)-FMK, respec-concomitant antagonism of Bim or Bad, and whether
tively) were added individually at 20 M in 0.05% DMSO. Peptideall are controlled by a common PI-3-kinase/Akt/NF-
B
Ac-Asp-Glu-Val-Asp-OH was added in DMSO as a control.pathway.
In summary, we provide evidence that OX40 repre-
Cytokine Secretion, Proliferation, Cell Division, Death
sents a crucial costimulatory molecule for CD4 T cells IL-2 was measured by ELISA using the Abs JES6-1A12 and biotin-
because it induces survival signals which prevent exces- JES6-5H4 (BD PharMingen). Proliferation was measured in triplicate
sive T cell death. The effect of these signals is observed by the incorporation of [3H]thymidine (1 Ci/well; ICN Pharmaceuti-
cals) during the last 12 hr of culture. To follow cell division, T cellsafter the phase of clonal expansion in the primary re-
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were labeled with 5- and 6-carboxyfluorescein diacetate succini- subfamily that bind TNF receptor-associated factors and activate
nuclear factor 
B. Mol. Cell. Biol. 18, 558–565.midyl ester (CFSE, C-1157; Molecular Probes) and analyzed by flow
cytometry. Apoptosis was assessed using annexin V conjugated to Bansal-Pakala, P., Jember, A.G.-H., and Croft, M. (2001). Signaling
PE (BD Pharmingen). through OX40 (CD134) breaks peripheral T cell tolerance. Nat. Med.
7, 907–912.
Western Blots Behrens, T.W., and Mueller, D.L. (1997). Bcl-x and the regulation of
T cells were spun through histopaque (Sigma), and lysed in ice-cold survival in the immune system. Immunol. Res. 16, 149–160.
TNE lysing buffer (1% NP-40, 20 mM Tris-HCl [pH 7.6], 150 mM NaCl,
Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten,5 mM EDTA, 1 mM PMSF, and 10 g/ml aprotinin and leupeptin) for
T., Turka, L.A., Mao, X., Nunez, G., and Thompson, C.B. (1993). bcl-x,30 min. Insoluble material was removed and lysates were stored at
a bcl-2-related gene that functions as a dominant regulator of apo-
80C. Protein content was determined by bicinchoninic acid pro-
ptotic cell death. Cell 74, 597–608.tein assay kit (Pierce). Equal amounts (50 g) were loaded onto
Boise, L.H., Minn, A.J., Noel, P.J., June, C.H., Accavitti, M.A., Lind-12.5% acrylamide gels (SDS-PAGE), transferred onto Immobolin-P
sten, T., and Thompson, C.B. (1995). CD28 costimulation can pro-membrane (Millipore), and immunoblotted with various antibodies.
mote T cell survival by enhancing the expression of Bcl-xL. ImmunityBinding of polyclonal rabbit antibodies to mouse/human Bcl-xL
3, 87–98.(Transduction Laboratories), mouse Bcl-2, and mouse Bax (BD Phar-
mingen) were detected with peroxidase-conjugated donkey anti- Bouillet, P., Metcalf, D., Huang, D.C., Tarlinton, D.M., Kay, T.W.,
rabbit Ig (Amersham Life Sciences). Binding of monoclonal mouse Kontgen, F., Adams, J.M., and Strasser, A. (1999). Proapoptotic Bcl-2
antibodies to human Bcl-2 (BD Pharmingen) and mouse actin (ICN relative Bim required for certain apoptotic responses, leukocyte
Biomedical) were detected with peroxidase-conjugated goat anti- homeostasis, and to preclude autoimmunity. Science 286, 1735–
mouse Ig (Southern Biotech). Blots were developed with ECL immu- 1738.
nodetection system (Sigma) and Kodak film. Band intensities were Brocker, T., Gulbranson-Judge, A., Flynn, S., Riedinger, M., Ray-
quantitated using a computing densitometer with NIH Image 1.61 kundalia, C., and Lane, P. (1999). CD4 T cell traffic control: in vivo
software. evidence that ligation of OX40 on CD4 T cells by OX40-ligand ex-
pressed on dendritic cells leads to the accumulation of CD4 T cells
Retroviral Transduction in B follicles. Eur. J. Immunol. 29, 1610–1616.
The murine stem cell virus (MSCV) 2.2 vector containing cDNA for Calderhead, D.M., Buhlmann, J.E., van den Eertwegh, A.J., Claas-
Bcl-xL was a generous gift of Dr. Abul Abbas (University of California, sen, E., Noelle, R.J., and Fell, H.P. (1993). Cloning of mouse Ox40:
San Francisco; Dahl et al., 2000). This vector was originally modified a T cell activation marker that may mediate T-B cell interactions. J.
to contain an internal ribosome entry site and the cDNA of green Immunol. 151, 5261–5271.
fluorescent protein (Ouyang et al., 1998). Subsequently, the cDNA
Chao, D.T., Linette, G.P., Boise, L.H., White, L.S., Thompson, C.B.,for human Bcl-xL (Boise et al., 1993) was cloned into an XhoI site
and Korsmeyer, S.J. (1995). Bcl-XL and Bcl-2 repress a common(Dahl et al., 2000). cDNA for human Bcl-2 was kindly provided by
pathway of cell death. J. Exp. Med. 182, 821–828.Dr. Doug Green (LIAI) and subcloned into the empty vector at BglII
Chen, A.I., McAdam, A.J., Buhlmann, J.E., Scott, S., Lupher, M.L.,and XhoI sites. The virus was produced by chloroquine-mediated
Jr., Greenfield, E.A., Baum, P.R., Fanslow, W.C., Calderhead, D.M.,calcium phosphate transfection of the Phoenix E ecotropic packag-
Freeman, G.J., and Sharpe, A.H. (1999). Ox40-ligand has a criticaling cell line (Costa et al., 2000). Supernatants were collected after
costimulatory role in dendritic cell:T cell interactions. Immunity 11,3 days, titered by measuring GFP expression, and used directly for
689–698.transducing T cells. 5  105 T cells were stimulated with peptide and
APCs in 48-well plates as described. After 2 days, the supernatant Costa, G.L., Benson, J.M., Seroogy, C.M., Achacoso, P., Fathman,
was replaced with 1 ml viral supernatant containing 5 g/ml Poly- C.G., and Nolan, G.P. (2000). Targeting rare populations of murine
brene, and the cells were spun for 3 hr at 32C and then incubated antigen-specific T lymphocytes by retroviral transduction for poten-
at 32C for 8 hr. This procedure was repeated the following day. tial application in gene therapy for autoimmune disease. J. Immunol.
Viral supernatant was removed and replaced with fresh medium, 164, 3581–3590.
and T cells were recultured for up to 9 more days. Expression of Croft, M., and Dubey, C. (1997). Accessory molecule and costimula-
GFP was determined by flow cytometry gating on V3-positive cells. tion requirements for CD4 T cell response. Crit. Rev. Immunol. 17,
89–118.
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